These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27353264)

  • 21. Differential efficacy of clarithromycin in lung versus thigh infection models.
    Maglio D; Capitano B; Banevicius MA; Geng Q; Nightingale CH; Nicolau DP
    Chemotherapy; 2004 Jun; 50(2):63-6. PubMed ID: 15211079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eravacycline for the treatment of intra-abdominal infections.
    Bassetti M; Righi E
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1575-84. PubMed ID: 25251475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Jan; 50(1):243-9. PubMed ID: 16377693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.
    Zhang Y; Lin X; Bush K
    J Antibiot (Tokyo); 2016 Aug; 69(8):600-4. PubMed ID: 27353166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.
    Lepak AJ; Parhi A; Madison M; Marchillo K; VanHecker J; Andes DR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6568-74. PubMed ID: 26259789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo pharmacodynamic activity of the glycopeptide dalbavancin.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2007 May; 51(5):1633-42. PubMed ID: 17307987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic antibacterial activity of novel synthetic cyclic peptides.
    Dartois V; Sanchez-Quesada J; Cabezas E; Chi E; Dubbelde C; Dunn C; Granja J; Gritzen C; Weinberger D; Ghadiri MR; Parr TR
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3302-10. PubMed ID: 16048940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
    Sun C; Hunt DK; Chen CL; Deng Y; He M; Clark RB; Fyfe C; Grossman TH; Sutcliffe JA; Xiao XY
    J Med Chem; 2015 Jun; 58(11):4703-12. PubMed ID: 25927406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model.
    Mavridou E; Melchers RJ; van Mil AC; Mangin E; Motyl MR; Mouton JW
    Antimicrob Agents Chemother; 2015 Feb; 59(2):790-5. PubMed ID: 25403667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
    Tessier PR; Mattoes HM; Dandekar PK; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.
    Guo C; Liao X; Wang M; Wang F; Yan C; Xiao X; Sun J; Liu Y
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1114-20. PubMed ID: 26666923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parameters.
    Grossman TH; Pillar CM; Sahm DF; Sutcliffe JA
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2426-7. PubMed ID: 25605350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of levofloxacin in Japanese quails (Coturnix japonica) following intravenous and oral administration.
    Aboubakr M
    Br Poult Sci; 2012; 53(6):784-9. PubMed ID: 23398423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on tetracyclines.
    Shlaes DM
    Curr Opin Investig Drugs; 2006 Feb; 7(2):167-71. PubMed ID: 16499287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of protein synthesis.
    Leviton I
    Cancer Invest; 1999; 17(1):87-92. PubMed ID: 10999052
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of cefovecin in cats.
    Stegemann MR; Sherington J; Coati N; Brown SA; Blanchflower S
    J Vet Pharmacol Ther; 2006 Dec; 29(6):513-24. PubMed ID: 17083455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.